StockData
Baxter International Inc logo

Baxter International Inc (BAX) stock

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$25.76+0.22 (+0.86%)

Close on Nov 17, 2026Market cap $13.33BP/E –Yield 2.02%

Baxter International total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Baxter International's total debt was $844.00M at Sep 30, 2026. For fiscal 2025 it was $9.48B, down 27.8% from the year before. Over ten years it grew 3.8% a year on average. The highest annual figure on record is $17.66B in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.48B-27.8%
FY2024Dec 31, 2024$13.13B-4.6%
FY2023Dec 31, 2023$13.76B-17.3%
FY2022Dec 31, 2022$16.64B-5.8%
FY2021Dec 31, 2021$17.66B+185.2%
FY2020Dec 31, 2020$6.19B+15.7%
FY2019Dec 31, 2019$5.35B+53.5%
FY2018Dec 31, 2018$3.49B-0.8%
FY2017Dec 31, 2017$3.51B+26.2%
FY2016Dec 31, 2016$2.78B-57.2%
FY2015Dec 31, 2015$6.51B-27.9%
FY2014Dec 31, 2014$9.03B-1.5%
FY2013Dec 31, 2013$9.17B+54.6%
FY2012Dec 31, 2012$5.93B+14.1%
FY2011Dec 31, 2011$5.20B+18.4%
FY2010Dec 31, 2010$4.39B+5.7%
FY2009Dec 31, 2009$4.15B+16.3%
FY2008Dec 31, 2008$3.57B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$844.00M+11.8%
Q2 FY2026Jun 30, 2026$844.00M+10450.0%
Q1 FY2026Mar 31, 2026$842.00M+27.2%
Q4 FY2025Dec 31, 2025$9.48B-27.8%
Q3 FY2025Sep 30, 2025$755.00M-94.2%
Q2 FY2025Jun 30, 2025$8.00M-99.9%
Q1 FY2025Mar 31, 2025$662.00M-95.2%
Q4 FY2024Dec 31, 2024$13.13B-4.6%
Q3 FY2024Sep 30, 2024$12.94B-21.6%
Q2 FY2024Jun 30, 2024$12.90B-21.7%
Q1 FY2024Mar 31, 2024$13.73B-16.5%
Q4 FY2023Dec 31, 2023$13.76B-17.3%
Q3 FY2023Sep 30, 2023$16.49B+0.4%
Q2 FY2023Jun 30, 2023$16.48B+3940.0%
Q1 FY2023Mar 31, 2023$16.43B+3917.4%
Q4 FY2022Dec 31, 2022$16.64B-5.8%
Q3 FY2022Sep 30, 2022$16.43B+3122.0%
Q2 FY2022Jun 30, 2022$408.00M-10.7%
Q1 FY2022Mar 31, 2022$409.00M+0.5%
Q4 FY2021Dec 31, 2021$17.66B+185.2%
Q3 FY2021Sep 30, 2021$510.00M-29.8%
Q2 FY2021Jun 30, 2021$457.00M+43.3%
Q1 FY2021Mar 31, 2021$407.00M-24.1%
Q4 FY2020Dec 31, 2020$6.19B+15.7%
Q3 FY2020Sep 30, 2020$727.00M+36250.0%
Q2 FY2020Jun 30, 2020$319.00M-93.8%
Q1 FY2020Mar 31, 2020$536.00M-87.4%
Q4 FY2019Dec 31, 2019$5.35B+53.5%
Q3 FY2019Sep 30, 2019$2.00M-99.9%
Q2 FY2019Jun 30, 2019$5.16B+47.7%
Q1 FY2019Mar 31, 2019$4.25B+19.6%
Q4 FY2018Dec 31, 2018$3.49B-0.8%
Q3 FY2018Sep 30, 2018$3.48B-0.4%
Q2 FY2018Jun 30, 2018$3.49B+1.1%
Q1 FY2018Mar 31, 2018$3.55B+27.5%
Q4 FY2017Dec 31, 2017$3.51B+26.2%
Q3 FY2017Sep 30, 2017$3.50B–
Q2 FY2017Jun 30, 2017$3.46B–
Q1 FY2017Mar 31, 2017$2.79B–
Q4 FY2016Dec 31, 2016$2.78B–

More Baxter International figures

See a number that looks wrong?